Fiserv Investor Day Lays Out AI and Clover Roadmap, Targets $12 EPS by 2029

What happened

Fiserv held its 2026 Investor Day on May 14, outlining a medium-term plan to restore growth and profitability after recent service and retention challenges. Management set ambitious targets including adjusted EPS above $12.00 by 2029, adjusted operating margin exceeding 37%, and adjusted revenue CAGR of 4%-6% from 2026-2029. The roadmap hinges on the 'One Fiserv' service improvement plan, Project Elevate for margin expansion, and AI initiatives like agentOS, alongside sustained Clover growth. However, the company's Q1 2026 results showed revenue declining 2% YoY to $5.027B and operating margin falling to 18.3% from 27.2%, with Financial Solutions core counts down 2% YoY. The Investor Day's explicit multi-year targets raise the bar for execution, with Q2 2026 expected to be the trough and Q3 2026 a key test for core count stabilization.

Implication

The Investor Day targets offer a credible long-term path, but the next two quarters are critical to validate the turnaround narrative. Q2 2026 must confirm the 'trough' in revenue decline, while Q3 2026 needs to show core count stabilization in Financial Solutions to prevent further erosion. Failure to hit these milestones would undermine the bull case and likely push the stock toward the bear case of $55. Conversely, if management delivers on service improvements translating into retention, the stock could re-rate toward the base case of $80. Investors should monitor agentOS adoption and Clover GPV growth as leading indicators, with the stock's low P/E of 8.9x offering a margin of safety only if execution improves.

Thesis delta

The Investor Day adds concrete multi-year targets that sharpen the investment thesis from a vague repair story to a measurable turnaround with explicit financial goals. However, the wide gap between current performance (negative organic growth, compressed margins) and 2029 targets ($12+ EPS, 37%+ margin) means the stock's valuation remains contingent on flawless execution over the next 2-3 quarters. The thesis shifts from 'is the company fixing itself?' to 'can it hit the milestones on time?'